Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanqing He

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Health Security|September 23, 2017
Timeliness of Measles Laboratory Reporting and Factors Associated with Delays, Zhejiang Province, China, 2009-2015Hanqing He, Rui Yan, Chunhong Fan, et al.
Scientific Reports|April 9, 2024
The effect analysis of shape design of different charging piles based on Human physiological characteristics using the MF-DFAYusheng Zhang, Yaoyuan Kang, Xin Guo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
The case of a new sequence type 7 serogroup X Neisseria meningitidis infection in China: may capsular switching change serogroup profile?Jinren Pan, Pingping Yao, Heng Zhang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 28, 2015
[Investigation and response for the first case of group X meningococcal disease in Zhejiang province]Heng Zhang, Jinren Pan, Pingping Yao, et al.
Frontiers in Public Health|July 2, 2026
Surveillance and analysis of adverse events following immunization (AEFI) with measles, mumps, and rubella (MMR) vaccine in Zhejiang Province, China, 2020-2025Xuejiao Pan, Yaping Chen, Hanqing He, et al.
Nature Reviews. Drug Discovery|July 9, 2026
Addressing challenges in treating rare tumours: the strategy of China's National Cancer CenterShuhang Wang, Jiawei Zhou, Hanqing He, et al.
Vaccine|August 5, 2019
Study on factors associated with seroprotection after measles vaccination in children of 6-14 years in Eastern ChinaRui Yan, Hanqing He, Yang Zhou, et al.
Frontiers in Public Health|May 15, 2026
Factors associated with serious adverse event following immunization: a real-world analysis of the vaccine adverse event reporting system 2025Xuejiao Pan, Yaping Chen, Fuxing Chen, et al.
Human Vaccines & Immunotherapeutics|January 15, 2021
Intention to accept pertussis vaccination among Chinese people older than age 5Xuewen Tang, Tingting Tang, Rui Yan, et al.
BMC Infectious Diseases|December 1, 2016
Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndromeHanqing He, Rui Yan, Xuewen Tang, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Health Security|September 23, 2017
Timeliness of Measles Laboratory Reporting and Factors Associated with Delays, Zhejiang Province, China, 2009-2015Hanqing He, Rui Yan, Chunhong Fan, et al.
Scientific Reports|April 9, 2024
The effect analysis of shape design of different charging piles based on Human physiological characteristics using the MF-DFAYusheng Zhang, Yaoyuan Kang, Xin Guo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
The case of a new sequence type 7 serogroup X Neisseria meningitidis infection in China: may capsular switching change serogroup profile?Jinren Pan, Pingping Yao, Heng Zhang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 28, 2015
[Investigation and response for the first case of group X meningococcal disease in Zhejiang province]Heng Zhang, Jinren Pan, Pingping Yao, et al.
Frontiers in Public Health|July 2, 2026
Surveillance and analysis of adverse events following immunization (AEFI) with measles, mumps, and rubella (MMR) vaccine in Zhejiang Province, China, 2020-2025Xuejiao Pan, Yaping Chen, Hanqing He, et al.
Nature Reviews. Drug Discovery|July 9, 2026
Addressing challenges in treating rare tumours: the strategy of China's National Cancer CenterShuhang Wang, Jiawei Zhou, Hanqing He, et al.
Vaccine|August 5, 2019
Study on factors associated with seroprotection after measles vaccination in children of 6-14 years in Eastern ChinaRui Yan, Hanqing He, Yang Zhou, et al.
Frontiers in Public Health|May 15, 2026
Factors associated with serious adverse event following immunization: a real-world analysis of the vaccine adverse event reporting system 2025Xuejiao Pan, Yaping Chen, Fuxing Chen, et al.
Human Vaccines & Immunotherapeutics|January 15, 2021
Intention to accept pertussis vaccination among Chinese people older than age 5Xuewen Tang, Tingting Tang, Rui Yan, et al.
BMC Infectious Diseases|December 1, 2016
Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndromeHanqing He, Rui Yan, Xuewen Tang, et al.
Pageof 10